DEBORAH CALARIS: Open Payments
NPI 1811086283 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$210 in 5 payments from 2 companies in 2025. Trend: 2023 $133 · 2024 $81 · 2025 $210
Food & beverage: $210
| Company | Payments | Amount |
|---|---|---|
| Intercept Pharmaceuticals, Inc. | 2 | $148 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $62 |
Products named: OCALIVA, XIFAXAN.
Industry payments across TX — which companies pay providers there.
